ACTH

Adrenocorticotropic Hormone
Shipped with Ice Packs
In Stock

Description

Synthesis and Molecular Structure

ACTH is derived from proopiomelanocortin (POMC), a precursor molecule cleaved by proteases into biologically active peptides. The cleavage process yields:

Peptide FragmentAlias/AbbreviationAmino Acid ResiduesFunction
NPPNPP27–102Unknown
γ-MSHγ-MSH77–87Pigmentation regulation
ACTHACTH138–176Cortisol and androgen stimulation
α-MSHα-MSH138–150Skin pigmentation
β-LPHβ-LPH179–267Lipid metabolism
β-Endorphinβ-Endorphin237–267Pain suppression

Key Regulatory Drivers

  • Circadian Rhythm: ACTH peaks at 06:00–08:00 hours .

  • Stress Response: Acute stress triggers rapid CRH release, overriding circadian patterns .

  • Glucocorticoid Feedback: Cortisol inhibits POMC transcription and CRH secretion .

Clinical Disorders and Diagnostic Tests

Abnormal ACTH levels indicate adrenal or pituitary dysfunction.

Common Disorders

ConditionACTH LevelPathophysiology
Primary Adrenal Insufficiency (Addison’s Disease)↑↑↑Adrenal cortex unable to respond to ACTH
Secondary Adrenal Insufficiency↓↓Pituitary ACTH deficiency (e.g., hypopituitarism)
Cushing’s Disease↑↑Pituitary tumor secreting excess ACTH
Ectopic ACTH Syndrome↑↑↑Non-pituitary tumors (e.g., lung carcinoids)

Diagnostic Tests

TestPurposeExpected Outcome
ACTH Stimulation TestAssess adrenal response to synthetic ACTHCortisol >12.6 µg/dL post-stimulation = normal
Inferior Petrosal Sinus Sampling (IPSS)Distinguish pituitary vs. ectopic ACTH sourceCentral-to-peripheral ACTH gradient >2:1 = pituitary source

Diagnostic Accuracy (from JCEM meta-analysis ):

ParameterHigh-Dose Test (250 µg)Low-Dose Test (1 µg)
Sensitivity64%83%
Specificity93%86%

Stress and ACTH Dysregulation

  • Childhood Trauma: Adults with maltreatment histories show blunted cortisol/ACTH responses to psychosocial stress .

  • Depression: Altered 24-hour ACTH pulsatility patterns in depressed individuals .

Non-Canonical Roles of ACTH

  • Adrenal Apoptosis: In vitro studies show ACTH induces cell death in adrenal cortex cultures .

  • Trophic Effects: ACTH promotes adrenal vascularization and cell differentiation in vivo .

Ectopic ACTH Challenges

  • Delayed Diagnosis: Case reports highlight occult ectopic ACTH tumors detected decades post-diagnosis (e.g., pancreatic NET after 16 years) .

Product Specs

Introduction
Adrenocorticotropic hormone (ACTH) is a hormone produced by the pituitary gland that stimulates the adrenal cortex to release cortisol. Cortisol is a steroid hormone that plays a role in the body's stress response, metabolism, and immune system. ACTH has little effect on the production of aldosterone, another steroid hormone produced by the adrenal cortex. ACTH also stimulates the growth of the adrenal cortex.
Description
Adrenocorticotropic Hormone has a molecular formula of C136H210N40O31S and a molecular weight of 2933.5 Da.
Physical Appearance
Sterile white lyophilized powder.
Formulation
The ACTH hormone was lyophilized without any additional ingredients.
Solubility
To reconstitute the lyophilized ACTH, it is recommended to dissolve it in sterile 18MΩ-cm H2O to a concentration of at least 100 µg/ml. This solution can then be further diluted in other aqueous solutions.
Stability
Lyophilized Adrenocorticotropic Hormone, while stable at room temperature for up to 3 weeks, should be stored in a dry environment below -18°C. Once reconstituted, ACTH should be stored at 4°C for 2-7 days. For long-term storage, freezing below -18°C is recommended. It is advisable to add a carrier protein such as 0.1% HSA or BSA for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of this product is greater than 98.0% as determined by RP-HPLC and SDS-PAGE analysis.
Synonyms
Corticotropin-lipotropin, Pro-opiomelanocortin, POMC, ACTH, LPH, MSH, NPP, POC, CLIP, Tetracosactide.
Amino Acid Sequence
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH.

Q&A

What is ACTH and what are its primary functions in endocrine regulation?

ACTH (adrenocorticotropic hormone) is a hormone produced in the anterior pituitary gland that plays a pivotal role in the hypothalamic-pituitary-adrenal (HPA) axis. The primary function of ACTH is to regulate the production and release of cortisol from the adrenal cortex. When released, ACTH travels through the bloodstream to the adrenal glands, where it stimulates the production of glucocorticoids, primarily cortisol .

Physiologically, ACTH regulates several essential functions through its control of cortisol, including:

  • Blood pressure maintenance

  • Blood glucose regulation

  • Immune system modulation

  • Stress response coordination

  • Inflammatory response regulation

ACTH follows a diurnal rhythm, with levels typically highest in the early morning and lowest at night. This pattern directly influences cortisol production, which follows the same circadian rhythm but with a slight delay after ACTH stimulation .

What are the reference ranges for ACTH testing, and how should timing considerations affect research protocols?

When designing research protocols involving ACTH measurement, timing considerations are critical:

  • Blood collection should ideally be performed in the early morning (typically between 6-8 AM) when ACTH levels reach their physiological peak

  • Standardized collection times should be maintained across all research subjects to minimize variability

  • Subjects should be instructed to avoid glucocorticoid medications before testing as these can affect test results

  • Researchers should account for the pulsatile secretion pattern of ACTH when interpreting results

For longitudinal studies, maintaining consistent sampling times is essential for valid comparisons between measurements over time.

How does the relationship between ACTH and cortisol vary in different pathological states?

The reciprocal relationship between ACTH and cortisol is disrupted in various endocrine disorders, creating distinctive patterns that assist in differential diagnosis . Understanding these patterns is crucial for research focused on endocrine pathophysiology.

DiseaseCortisol PatternACTH PatternPathophysiological Mechanism
Cushing's diseaseIncreasedIncreasedACTH-producing pituitary tumor (usually benign)
Adrenal tumorIncreasedDecreasedAutonomous cortisol production suppressing ACTH
Ectopic ACTH syndromeIncreasedIncreasedACTH production outside pituitary (commonly lung tumors)
Addison's diseaseDecreasedIncreasedPrimary adrenal insufficiency with compensatory ACTH elevation
HypopituitarismDecreasedDecreased or normalPituitary dysfunction affecting ACTH production

The interplay between ACTH and cortisol in these conditions provides valuable research insights into feedback mechanisms within the HPA axis. Researchers should design studies with simultaneous measurement of both hormones to properly interpret results .

What factors contribute to variability in ACTH assay results across laboratories, and how can this impact research validity?

Research examining ACTH assay variability has revealed significant concerns that can impact study validity and clinical research applications. A multicenter study evaluating seven different ACTH assays across 35 laboratories found considerable variability in measurement precision and accuracy .

Key findings regarding ACTH assay variability include:

These variability issues present significant challenges for multi-center research and meta-analyses. Researchers should implement several strategies to address these limitations:

  • Pre-study validation of assay performance at participating laboratories

  • Use of common calibration standards across sites

  • Implementation of quality control procedures

  • Consideration of centralized testing for critical measurements

  • Detailed documentation of assay methodology in research protocols and publications

What are the best practices for conducting an ACTH stimulation test in research settings?

The ACTH stimulation test (also known as the cosyntropin stimulation test) is a powerful research tool for evaluating adrenal function and reserve. For optimal results and research reliability, investigators should follow these methodological considerations:

  • Pre-test preparation:

    • Schedule testing for early morning to account for diurnal variation

    • Ensure subjects discontinue steroid medications that may interfere with results (with appropriate medical supervision)

    • Document recent medication use that might affect the hypothalamic-pituitary-adrenal axis

    • Establish a consistent fasting protocol across subjects

  • Testing procedure:

    • Obtain baseline blood samples for both ACTH and cortisol measurement

    • Administer synthetic ACTH (cosyntropin) via intramuscular injection at standardized dosage

    • Collect follow-up blood samples at precisely timed intervals (typically 30 and/or 60 minutes post-injection)

    • Process and analyze all samples according to standardized laboratory protocols

  • Quality control measures:

    • Use consistent laboratory methods across all samples

    • Implement blinding procedures when appropriate

    • Include control subjects for comparison

    • Consider the documented limitations in assay performance for low ACTH concentrations

Researchers should be aware that test interpretation requires consideration of both baseline values and the cortisol response to stimulation, with patterns of response providing insights into the location of endocrine dysfunction (pituitary versus adrenal).

How can researchers address the challenges of detecting and accurately measuring low ACTH concentrations?

Accurate measurement of low ACTH concentrations represents a particular challenge in endocrine research, with significant implications for studying conditions like adrenal tumors and secondary adrenal insufficiency. Research has demonstrated that current field ACTH assays correctly classify only about 60% of measurements from patients with low ACTH values .

Methodological approaches to improve detection and measurement of low ACTH concentrations include:

  • Selection of appropriate assay technology:

    • High-sensitivity ACTH assays with improved lower limits of detection

    • Two-site immunometric assays that demonstrate better performance at lower concentrations

    • Mass spectrometry-based methods for research requiring highest precision

  • Sample handling optimization:

    • Immediate processing and freezing of plasma samples

    • Use of appropriate anticoagulants and enzyme inhibitors to prevent ACTH degradation

    • Minimization of freeze-thaw cycles before analysis

  • Statistical approaches:

    • Application of appropriate statistical methods for values near detection limits

    • Consideration of measurement uncertainty in data interpretation

    • Validation of findings using secondary methodologies when critical

  • Standardization efforts:

    • Use of internationally recognized reference materials

    • Participation in external quality assessment programs

    • Development and implementation of standardized protocols between research groups

Researchers should explicitly acknowledge these limitations when publishing studies involving low ACTH measurements and consider whether alternative markers might provide complementary information.

How does ACTH measurement contribute to differential diagnosis of Cushing's syndrome, and what methodological considerations are important?

ACTH measurement plays a critical role in differentiating between various forms of Cushing's syndrome. The methodological approach to this differential diagnosis involves a systematic evaluation of both ACTH and cortisol levels, often with additional dynamic testing .

Differential diagnosis patterns and considerations:

  • ACTH-dependent Cushing's syndrome:

    • Characterized by elevated or inappropriate normal ACTH levels with hypercortisolism

    • Further differentiation required between pituitary source (Cushing's disease) and ectopic ACTH production

    • Additional tests such as dexamethasone suppression testing and CRH stimulation help distinguish between sources

    • Sampling from petrosal sinuses may be necessary in research protocols examining pituitary ACTH production

  • ACTH-independent Cushing's syndrome:

    • Characterized by suppressed ACTH levels (<5 pg/mL) with hypercortisolism

    • Typically caused by adrenal tumors or hyperplasia

    • Research protocols should include imaging studies to correlate with biochemical findings

    • Genetic testing may provide additional insights in research contexts

Methodological considerations specific to Cushing's syndrome research include:

  • The need for multiple measurements due to pulsatile hormone secretion

  • Appropriate timing of samples to account for disrupted circadian rhythm

  • Consideration of assay limitations in the presence of interfering substances

  • Selection of appropriate cut-off values based on assay characteristics and study population

What are the current challenges and approaches to standardizing ACTH assays in research and clinical practice?

ACTH assay standardization remains an ongoing challenge for both researchers and clinicians. Field ACTH assays demonstrate high variability and often fail to correctly identify patients with suppressed ACTH secretion . Addressing these standardization issues requires a multifaceted approach:

  • Current challenges in ACTH standardization:

    • Lack of universally accepted reference materials

    • Variability in antibody specificity between immunoassays

    • Differences in cross-reactivity with ACTH fragments and precursors

    • Pre-analytical variables affecting sample stability

    • Limited harmonization between manufacturers' calibration procedures

  • Approaches to improving standardization:

    • Development and implementation of international reference preparations

    • Harmonization of calibration procedures across manufacturers

    • Establishment of standardized sample collection and handling protocols

    • Implementation of external quality assessment programs specific to ACTH

    • Development of mass spectrometry-based reference methods

  • Research implications:

    • Clear documentation of assay methodology in research publications

    • Reporting of assay-specific reference ranges

    • Consideration of method-specific cut-offs for diagnostic criteria

    • Caution in comparing absolute values between studies using different methodologies

The endocrine community has recognized the need to include ACTH assays among those requiring standardization, similar to efforts already undertaken for other hormones .

How might advances in mass spectrometry and other emerging technologies improve ACTH measurement in research settings?

While current immunoassay methods for ACTH measurement face standardization challenges, emerging technologies offer promising alternatives that may address these limitations:

  • Mass spectrometry-based approaches:

    • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) provides higher specificity

    • Ability to distinguish between intact ACTH and fragments

    • Potential for simultaneous measurement of multiple HPA axis components

    • Reduced vulnerability to antibody cross-reactivity issues

    • Improved accuracy at low concentrations when using appropriate extraction and concentration techniques

  • Digital immunoassay platforms:

    • Single molecule counting technologies offer improved sensitivity

    • Potential for expanded dynamic range

    • Reduced sample volume requirements beneficial for longitudinal studies

    • Enhanced precision at lower concentrations

  • Point-of-care testing developments:

    • Microfluidic approaches for rapid analysis

    • Potential for reduced pre-analytical variability

    • Applications in stress research with real-time monitoring

  • Multiplex assay systems:

    • Simultaneous measurement of ACTH and related peptides

    • Comprehensive assessment of HPA axis components

    • Potential for new biomarker discovery when combined with bioinformatics approaches

These technological advances may significantly improve research capabilities, particularly for studies focused on conditions with subtle alterations in HPA axis function or requiring repeated measurements over time.

What special considerations should researchers implement when interpreting ACTH results in the context of pulsatile secretion and circadian rhythm?

The pulsatile nature of ACTH secretion and its circadian rhythm present specific challenges for research design and data interpretation. Advanced research approaches should incorporate several methodological considerations:

  • Sampling strategies for pulsatility assessment:

    • Frequent sampling protocols (every 10-15 minutes) to capture secretory episodes

    • Standardized collection conditions to minimize stress-induced fluctuations

    • Consideration of ultradian rhythms in addition to circadian patterns

    • Mathematical modeling of pulse frequency and amplitude

  • Circadian rhythm evaluation approaches:

    • 24-hour sampling protocols with standardized intervals

    • Controlling for environmental factors affecting rhythm (light exposure, sleep patterns)

    • Consideration of sleep quality and shift work in study participants

    • Application of cosinor analysis and other chronobiological statistical methods

  • Normalization and reference range considerations:

    • Development of time-specific reference ranges

    • Use of z-scores or similar standardization approaches for comparing values at different times

    • Implementation of area-under-the-curve calculations for integrated assessment

    • Consideration of individual variation in rhythm timing and amplitude

  • Specific research applications:

    • Studies of stress disorders may require evaluation of rhythm disruption

    • Sleep research benefits from coordination of sampling with polysomnography

    • Metabolic research should consider relationships between ACTH rhythm and glucose metabolism

These approaches enable more sophisticated analysis of HPA axis function beyond simple point measurements, potentially revealing subtle dysregulation not apparent in isolated samples.

Product Science Overview

Production and Regulation

ACTH is derived from a precursor protein called pro-opiomelanocortin (POMC). The cleavage of POMC produces ACTH along with other peptides such as melanocyte-stimulating hormone (MSH) and β-endorphin . The production and release of ACTH are regulated by the hypothalamus through the secretion of corticotropin-releasing hormone (CRH). When CRH is released, it stimulates the anterior pituitary gland to secrete ACTH .

Function

The primary function of ACTH is to stimulate the adrenal glands to produce and release cortisol, a glucocorticoid hormone often referred to as the "stress hormone" . Cortisol has several vital functions, including:

  • Regulating the body’s stress response
  • Controlling the use of fats, proteins, and carbohydrates (metabolism)
  • Suppressing inflammation
  • Regulating blood pressure
  • Regulating blood sugar levels
  • Helping control the sleep-wake cycle

In addition to cortisol, ACTH also stimulates the adrenal glands to release androgens, which are sex hormones .

Clinical Significance

Abnormal levels of ACTH can indicate various medical conditions. For instance, elevated ACTH levels can be a sign of primary adrenal insufficiency (e.g., Addison’s disease), where the adrenal glands do not produce enough cortisol . Conversely, low ACTH levels can indicate secondary adrenal insufficiency, often due to an impairment of the pituitary gland or hypothalamus .

In some cases, ACTH is used as a medication and diagnostic agent. For example, it can be administered to test the adrenal glands’ response in diagnosing adrenal insufficiency .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.